Regulator

(redirected from regulatory agency)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.

Regulator

An agency enforcing legislation and setting rules governing certain actions. For example, the Internal Revenue Service in the United States is a regulator because it collects taxes, enforcing the U.S. Tax Code. In securities, regulators often require companies to disclose their actions to see to it that as much information as possible is publicly available. Other regulators govern business practices. For example, they may enforce minimum or maximum wages and salaries, prohibit discrimination on certain grounds, and/or ban certain policies or practices deemed unfair for consumers or competitors. While nearly everyone agrees that some regulations are necessary, there is significant disagreement as to how many and what kind are needed. Proponents of more regulation assert that it ensures a fair market and sustainable growth, while critics argue that many regulations do more harm than good.
References in periodicals archive ?
The Medicines and Healthcare products Regulatory Agency (MHRA) is the UK equivalent to Australia's Therapeutic Goods Administration (TGA) and USA's Food and Drug Administration (FDA).
A number of states have securities laws permitting public companies to raise a limited amount of capital without submitting audited financial statements to the state regulatory agency.
The owner or the regulatory agency can then proceed against the responsible party.
GPC Biotech AG (Frankfurt Stock Exchange: GPC; TecDAX 30) has received three important permits from the responsible German regulatory agency for the company's fully human oncology monoclonal antibody, 1D09C3.
These factors include, but are not limited to: (i) whether we will receive, and the potential timing and scope of, regulatory approvals or clearances to market CUBICIN in other countries pursuant to our currently planned filings and any filings we determine to make in the future, which filings are subject to approval by the applicable regulatory agency or agencies, regardless of our confidence in the results of the clinical trials supporting such filings; (ii)the level of acceptance of CUBICIN by physicians, patients, third party payors and the medical community; (iii)any changes in the current or anticipated market demand or medical need for CUBICIN; (iv)competition in the markets in which we and our partners market CUBICIN; (v)whether the U.

Full browser ?